Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T02:02:54.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning to use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI), with links to updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-25T02:02:30.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:43:44.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:10:53.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new revision tag v3.7.0 was added to the record history, indicating a newer version of the study record. The previous revision tag v3.6.6 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-20T00:56:54.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The revision history now lists Revision: v3.6.6 as the current version. The prior Revision: v3.6.5 entry has been removed.
    Difference
    0.1%
    Check dated 2026-08-29T18:44:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.